{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T17:37:01Z","timestamp":1776706621428,"version":"3.51.2"},"reference-count":26,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T00:00:00Z","timestamp":1592956800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancers"],"abstract":"<jats:p>High dose chemotherapy (HDT) followed by autologous peripheral blood stem cell transplantation (ASCT) is standard of care including a curative treatment option for several cancers. While much is known about the management of patients with allogenic SCT at the intensive care unit (ICU), data regarding incidence, clinical impact, and outcome of critical illness following ASCT are less reported. This study included 256 patients with different cancer entities. Median age was 56 years (interquartile ranges (IQR): 45\u201364), and 67% were male. One-year survival was 89%; 15 patients (6%) required treatment at the ICU following HDT. The main reason for ICU admission was septic shock (80%) with the predominant focus being the respiratory tract (53%). Three patients died, twelve recovered, and six (40%) were alive at one-year, resulting in an immediate treatment-related mortality of 1.2%. Independent risk factors for ICU admission were age (odds ratio (OR) 1.05; 95% confidence interval (CI) 1.00\u20131.09; p = 0.043), duration of aplasia (OR: 1.37; CI: 1.07\u20131.75; p = 0.013), and Charlson comorbidity score (OR: 1.64; CI: 1.20\u20132.23; p = 0.002). HDT followed by ASCT performed at an experienced centre is generally associated with a low risk for treatment related mortality. ICU treatment is warranted mainly due to infectious complications and has a strong positive impact on intermediate-term survival.<\/jats:p>","DOI":"10.3390\/cancers12061678","type":"journal-article","created":{"date-parts":[[2020,6,24]],"date-time":"2020-06-24T08:54:50Z","timestamp":1592988890000},"page":"1678","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Intensive Care Outcomes of Patients after High Dose Chemotherapy and Subsequent Autologous Stem Cell Transplantation: A Retrospective, Single Centre Analysis"],"prefix":"10.3390","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6459-7561","authenticated-orcid":false,"given":"Panagiotis","family":"Karagiannis","sequence":"first","affiliation":[{"name":"Department of Oncology, Haematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Centre Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"S\u00e4nger","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Winfried","family":"Alsdorf","sequence":"additional","affiliation":[{"name":"Department of Oncology, Haematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Centre Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katja","family":"Weisel","sequence":"additional","affiliation":[{"name":"Department of Oncology, Haematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Centre Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Fiedler","sequence":"additional","affiliation":[{"name":"Department of Oncology, Haematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Centre Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Kluge","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic","family":"Wichmann","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carsten","family":"Bokemeyer","sequence":"additional","affiliation":[{"name":"Department of Oncology, Haematology and Bone Marrow Transplantation with Section of Pneumology, University Medical Centre Hamburg-Eppendorf, Martinistrasse 52, 20246 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentin","family":"Fuhrmann","sequence":"additional","affiliation":[{"name":"Department of Intensive Care Medicine, University Medical Centre Hamburg-Eppendorf, 20246 Hamburg, Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2020,6,24]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/CCM.0b013e3181c0349e","article-title":"Characteristics and outcomes of patients with cancer requiring admission to intensive care units: A prospective multicenter study","volume":"38","author":"Soares","year":"2010","journal-title":"Crit Care Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"897","DOI":"10.3109\/0284186X.2012.679311","article-title":"Outcomes of cancer patients after unplanned admission to general intensive care units","volume":"51","author":"Bos","year":"2012","journal-title":"Acta Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1111\/j.1445-5994.2011.02533.x","article-title":"Intensive care unit experience of haemopoietic stem cell transplant patients","volume":"42","author":"Agarwal","year":"2012","journal-title":"Intern. Med. J."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2110-5820-1-5","article-title":"Intensive care of the cancer patient: Recent achievements and remaining challenges","volume":"1","author":"Azoulay","year":"2011","journal-title":"Ann. Intensiv. Care"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1093\/annonc\/mdl044","article-title":"High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults","volume":"17","author":"Pedrazzoli","year":"2006","journal-title":"Ann. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"4184","DOI":"10.1200\/JCO.2010.28.1618","article-title":"Salvage regimens with autologous transplantation for relapsed large B-cell lymphoma in the rituximab era","volume":"28","author":"Gisselbrecht","year":"2010","journal-title":"J. Clin. Oncol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1200\/JCO.2016.69.5395","article-title":"High-Dose Chemotherapy and Autologous Peripheral-Blood Stem-Cell Transplantation for Relapsed Metastatic Germ Cell Tumors: The Indiana University Experience","volume":"35","author":"Adra","year":"2017","journal-title":"J. Clin. Oncol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1200\/JCO.2012.47.2365","article-title":"Outcomes of critically ill patients with hematologic malignancies: Prospective multicenter data from France and Belgium\u2014A groupe de recherche respiratoire en reanimation onco-hematologique study","volume":"31","author":"Azoulay","year":"2013","journal-title":"J. Clin. Oncol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/j.1365-2141.2006.06204.x","article-title":"Outcome of autologous stem cell transplantation for AL amyloidosis in the UK","volume":"134","author":"Goodman","year":"2006","journal-title":"Br. J. Haematol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/sj.bmt.1700626","article-title":"Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow","volume":"19","author":"Reed","year":"1997","journal-title":"Bone Marrow Transplant."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1200\/JCO.1989.7.7.932","article-title":"Dose-intensive chemotherapy in refractory germ cell cancer\u2014A phase I\/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation","volume":"7","author":"Nichols","year":"1989","journal-title":"J. Clin. Oncol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1164\/ajrccm.158.3.9711076","article-title":"Prognostic indicators for blood and marrow transplant patients admitted to an intensive care unit","volume":"158","author":"Price","year":"1998","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/bmt.2008.336","article-title":"Predictors of mortality in patients undergoing autologous hematopoietic cell transplantation admitted to the intensive care unit","volume":"43","author":"Trinkaus","year":"2009","journal-title":"Bone Marrow Transplant."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1200\/JCO.2015.61.2267","article-title":"Revised International Staging System for Multiple Myeloma: A Report From International Myeloma Working Group","volume":"33","author":"Palumbo","year":"2015","journal-title":"J. Clin. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1200\/JCO.1985.3.3.353","article-title":"Patterns of recurrence in patients with high-grade soft-tissue sarcomas","volume":"3","author":"Potter","year":"1985","journal-title":"J. Clin. Oncol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/cncr.20152","article-title":"High-dose methotrexate pharmacokinetics and outcome of children and young adults with osteosarcoma","volume":"100","author":"Crews","year":"2004","journal-title":"Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1007\/s00134-003-1957-y","article-title":"Improved survival of critically ill cancer patients with septic shock","volume":"29","author":"Azoulay","year":"2003","journal-title":"Intensive Care Med."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1007\/s00063-019-0532-4","article-title":"Hematological-oncological intensive care patients: Treatment without borders","volume":"114","author":"Kochanek","year":"2019","journal-title":"Med. Klin. Intensivmed. Notfmed."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1007\/s00277-018-3312-y","article-title":"Consensus statement for cancer patients requiring intensive care support","volume":"97","author":"Kiehl","year":"2018","journal-title":"Ann. Hematol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"166","DOI":"10.5603\/AIT.2014.0030","article-title":"The effectiveness of the APACHE II, SAPS II and SOFA prognostic scoring systems in patients with haematological malignancies in the intensive care unit","volume":"46","author":"Sawicka","year":"2014","journal-title":"Anaesthesiol. Intensive Ther."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/qjmed\/hcq032","article-title":"ICU and 6-month outcome of oncology patients in the intensive care unit","volume":"103","author":"McGrath","year":"2010","journal-title":"QJM"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1016\/j.ajic.2018.05.003","article-title":"Patient- and hospital-level predictors of vancomycin-resistant Enterococcus (VRE) bacteremia in Ontario, Canada","volume":"46","author":"Johnstone","year":"2018","journal-title":"Am. J. Infect. Control."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Xie, O., Slavin, M.A., Teh, B.W., Bajel, A., Douglas, A.P., and Worth, L.J. (2020). Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting. BMC Infect. Dis., 20.","DOI":"10.1186\/s12879-020-04952-5"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00134-011-2344-8","article-title":"Outcomes of mechanically ventilated hematology patients with invasive pulmonary aspergillosis","volume":"37","author":"Burghi","year":"2011","journal-title":"Intensive Care Med."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.3324\/haematol.2010.031583","article-title":"Prognostic factors for intensive care unit admission, intensive care outcome, and post-intensive care survival in patients with de novo acute myeloid leukemia: A single center experience","volume":"96","author":"Schellongowski","year":"2011","journal-title":"Haematologica"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1097\/SHK.0b013e3182866d32","article-title":"Outcomes in critically ill cancer patients with septic shock of pulmonary origin","volume":"39","author":"Legrand","year":"2013","journal-title":"Shock"}],"container-title":["Cancers"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/6\/1678\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:42:22Z","timestamp":1760175742000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2072-6694\/12\/6\/1678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,24]]},"references-count":26,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6]]}},"alternative-id":["cancers12061678"],"URL":"https:\/\/doi.org\/10.3390\/cancers12061678","relation":{},"ISSN":["2072-6694"],"issn-type":[{"value":"2072-6694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,24]]}}}